XBIO Xenetic Biosciences Forecast, Technical & Fundamental Analysis

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

XBIO is expected to report earnings to rise 10.00% to -10 cents per share on May 17

Xenetic Biosciences XBIO Stock Earnings Reports

Q1'23

Est.

$-0.11

Q4'22

Est.

$-0.10

Q3'22

Est.

$-0.06

Q2'22

Est.

$-0.19

Q1'22

Est.

$-0.12

The last earnings report on March 23 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 10.30K shares outstanding, the current market capitalization sits at 6.66M.

A.I. Advisor

published General Information

General Information

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

945 Concord Street

Phone

+1 781 778-7720

Employees

Web

https://www.xeneticbio.com

Interesting Tickers

ETFs / NAME	Price $	Chg $	Chg %
		1 Day
SPY	577.99	-5.33	-0.91%
SPDR® S&P 500® ETF Trust
BTC.X	66432.195000	-929.210940	-1.38%
Bitcoin cryptocurrency
GME	20.54	-0.39	-1.86%
GameStop Corp
TSLA	213.65	-4.32	-1.98%
Tesla
AAPL	230.76	-5.10	-2.16%
Apple

XBIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then SYRE could also see price increases.

Ticker / NAME	Correlation To XBIO	1D Price Change %
XBIO	100%	-0.83%
SYRE - XBIO	34% Loosely correlated	-1.58%
VXRT - XBIO	29% Poorly correlated	-1.27%
EDSA - XBIO	29% Poorly correlated	-2.13%
CDTX - XBIO	28% Poorly correlated	-0.70%
AUTL - XBIO	27% Poorly correlated	+0.68%
More